Literature DB >> 9258771

Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.

T O Harville1, D M Adams, T A Howard, R E Ware.   

Abstract

Omenn syndrome comprises a rare form of combined immunodeficiency with TH2-type features of eosinophilia and elevated IgE. Previous studies have led to reports of restricted heterogeneity in the T lymphocyte repertoire, and in vitro cloned T lymphocytes have been shown to produce IL-4 and IL-5. We hypothesized that (1) T cell receptor beta V(D)J DNA sequence analysis would confirm and further define the putative restricted heterogeneity, and (2) increased production of IL-4 and IL-5 should be found in nonstimulated T lymphocytes, if the molecular pathogenesis of Omenn syndrome is an uncontrolled TH2 state. We report the results of molecular analyses of T lymphocytes from an untreated 3-month-old patient. Oligoclonal T cell receptor beta variable gene usage was found. Sequence analysis revealed sets of identical V(D)J sequences, each in-frame, with apparently normal N-diversification and no obvious antigen combining site motif. From fresh, nonstimulated lymphocytes, proinflammatory TH1 cytokines could be detected, but TH2 cytokines could not, so that a simple TH1/TH2 paradigm cannot explain the eosinophilia and elevated IgE in Omenn syndrome. Our studies fully document for the first time at the molecular level that clonally expanded populations of T lymphocytes are present in Omenn syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9258771     DOI: 10.1023/a:1027330800085

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  64 in total

1.  Clinical and immune recovery from Omenn syndrome after bone marrow transplantation.

Authors:  A K Junker; K W Chan; B G Massing
Journal:  J Pediatr       Date:  1989-04       Impact factor: 4.406

2.  Rapidly fatal familial histiocytosis associated with eosinophilia and primary immunological deficiency.

Authors:  R F Barth; G G Vergara; S K Khurana; J T Lowman; J B Beckwith
Journal:  Lancet       Date:  1972-09-09       Impact factor: 79.321

3.  Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells.

Authors:  S Wesselborg; O Janssen; D Kabelitz
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

4.  Induction of T cell CD7 gene transcription by nonmitogenic ionomycin-induced transmembrane calcium flux.

Authors:  R E Ware; M K Hart; B F Haynes
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

5.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

Authors:  B L Kotzin; S Karuturi; Y K Chou; J Lafferty; J M Forrester; M Better; G E Nedwin; H Offner; A A Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Tumor necrosis factor-alpha suppresses hematopoiesis in children with myelodysplasia.

Authors:  S S Winter; G A Hanissian; T O Harville; R E Ware
Journal:  Med Pediatr Oncol       Date:  1997-01

7.  Arrested rearrangement of TCR V beta genes in thymocytes from children with X-linked severe combined immunodeficiency disease.

Authors:  J W Sleasman; T O Harville; G B White; J F George; D J Barrett; M M Goodenow
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

8.  Combined immunodeficiency and reticuloendotheliosis with eosinophilia.

Authors:  H D Ochs; S D Davis; E Mickelson; K G Lerner; R J Wedgwood
Journal:  J Pediatr       Date:  1974-10       Impact factor: 4.406

9.  A common TCR beta-chain expressed by CD8+ intestinal mucosa T cells in ulcerative colitis.

Authors:  A Chott; C S Probert; G G Gross; R S Blumberg; S P Balk
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

10.  T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis.

Authors:  A Bonati; P Zanelli; S Ferrari; A Plebani; B Starcich; M Savi; T M Neri
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

View more
  14 in total

1.  Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system.

Authors:  X X Huang; M Yamashiki; K Nakatani; T Nobori; A Mase
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  R Zemble; E Luning Prak; K McDonald; D McDonald-McGinn; E Zackai; K Sullivan
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

3.  Omenn's Syndrome: A rare primary immunodeficiency disorder.

Authors:  Ibtisam B Elnour; Shakeel Ahmed; Kamal Halim; V Nirmala
Journal:  Sultan Qaboos Univ Med J       Date:  2007-08

4.  A variant of SCID with specific immune responses and predominance of gamma delta T cells.

Authors:  Stephan Ehl; Klaus Schwarz; Anselm Enders; Ulrich Duffner; Ulrich Pannicke; Joachim Kühr; Françoise Mascart; Annette Schmitt-Graeff; Charlotte Niemeyer; Paul Fisch
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

5.  Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.

Authors:  T Wada; K Takei; M Kudo; S Shimura; Y Kasahara; S Koizumi; K Kawa-Ha; Y Ishida; S Imashuku; H Seki; A Yachie
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

6.  Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome.

Authors:  Barbara Cassani; Pietro Luigi Poliani; Veronica Marrella; Francesca Schena; Aisha V Sauer; Maria Ravanini; Dario Strina; Christian E Busse; Stephan Regenass; Hedda Wardemann; Alberto Martini; Fabio Facchetti; Mirjam van der Burg; Antonius G Rolink; Paolo Vezzoni; Fabio Grassi; Elisabetta Traggiai; Anna Villa
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

7.  Omenn syndrome with mutation in RAG1 gene.

Authors:  I Cherkaoui Jaouad; K Ouldim; S Ali Ou Alla; Y Kriouile; A Villa; A Sefiani
Journal:  Indian J Pediatr       Date:  2008-11-15       Impact factor: 1.967

8.  AIRE deficiency in thymus of 2 patients with Omenn syndrome.

Authors:  Patrizia Cavadini; William Vermi; Fabio Facchetti; Stefania Fontana; Seiho Nagafuchi; Evelina Mazzolari; Anna Sediva; Veronica Marrella; Anna Villa; Alain Fischer; Luigi D Notarangelo; Raffaele Badolato
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 9.  Omenn syndrome: a disorder of Rag1 and Rag2 genes.

Authors:  A Villa; S Santagata; F Bozzi; L Imberti; L D Notarangelo
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

10.  A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome.

Authors:  Veronica Marrella; Pietro Luigi Poliani; Anna Casati; Francesca Rucci; Laura Frascoli; Marie-Lise Gougeon; Brigitte Lemercier; Marita Bosticardo; Maria Ravanini; Manuela Battaglia; Maria Grazia Roncarolo; Marina Cavazzana-Calvo; Fabio Facchetti; Luigi D Notarangelo; Paolo Vezzoni; Fabio Grassi; Anna Villa
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.